Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y

被引:7
作者
Uegaki, K [1 ]
Murase, S
Nemoto, N
Kobayashi, Y
Yoshikawa, S
Yumoto, N
机构
[1] Osaka Natl Res Inst, AIST, Ikeda, Osaka 563, Japan
[2] Tottori Univ, Fac Med, Dept Hlth Syst & Informat, Tottori 683, Japan
[3] Osaka Univ, Fac Pharmaceut Sci, Osaka 565, Japan
关键词
D O I
10.1006/bbrc.1997.7661
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To determine whether or not the dimeric structure of neuropeptide Y (NPY) that is found in solution is necessary for its function, we investigated the effects of covalent dimerization on the structure and function of NPY using the carboxy-terminal fragment, NPY(12-36), in which residues 12 and 31 (located at both ends of alpha-helical region) were replaced by Cys residues. Among the three species (the parallel dimer, the anti-parallel dimer, and the intramolecularly cross-linked monomer) obtained by oxidation of the fragment, the anti-parallel dimer was pre-dominant. NMR analysis showed that both parallel and anti-parallel dimers had alpha-helices similar to that of intact NPY, suggesting that covalent dimerization might have little effect on the helical structure. A binding assay with Y2 receptors on porcine hippocampal membranes revealed that the IC50 value of the anti-parallel dimer was almost the same as that of NPY(13-36), which is known as a Y2-specific ligand. By contrast, the binding by the parallel dimer was weaker by more than one order of magnitude. Our results suggest that the formation of dimers of NPY is not essential for binding to the receptor. (C) 1997 Academic Press.
引用
收藏
页码:737 / 743
页数:7
相关论文
共 27 条
[1]   CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN Y4 SUBTYPE RECEPTOR FOR PANCREATIC-POLYPEPTIDE, NEUROPEPTIDE-Y, AND PEPTIDE YY [J].
BARD, JA ;
WALKER, MW ;
BRANCHEK, TA ;
WEINSHANK, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) :26762-26765
[2]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF NEUROPEPTIDE-Y ANALOGS WITH RESPECT TO Y-1 AND Y-2 RECEPTORS [J].
BECKSICKINGER, AG ;
JUNG, G .
BIOPOLYMERS, 1995, 37 (02) :123-142
[3]  
BECKSICKINGER AG, 1997, NEUROPEPTIDE Y DRUG, P107
[4]  
BRNNGER AT, 1992, XPLOR VERSION 3 1 SY
[5]  
CHOK PW, 1995, LIFE SCI, V56, P1055
[6]   STRUCTURE OF NEUROPEPTIDE-Y DIMER IN SOLUTION [J].
COWLEY, DJ ;
HOFLACK, JM ;
PELTON, JT ;
SAUDEK, V .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 205 (03) :1099-1106
[7]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[8]   NEUROPEPTIDE-Y AND NEUROPEPTIDE-Y RECEPTOR SUBTYPES IN BRAIN AND PERIPHERAL-TISSUES [J].
DUMONT, Y ;
MARTEL, JC ;
FOURNIER, A ;
STPIERRE, S ;
QUIRION, R .
PROGRESS IN NEUROBIOLOGY, 1992, 38 (02) :125-167
[9]  
EDVINSSON L, 1988, ISI ATLAS-PHARMACOL, V2, P357
[10]   A COMMON-SENSE APPROACH TO PEAK PICKING IN 2-DIMENSIONAL, 3-DIMENSIONAL, AND 4-DIMENSIONAL SPECTRA USING AUTOMATIC COMPUTER-ANALYSIS OF CONTOUR DIAGRAMS [J].
GARRETT, DS ;
POWERS, R ;
GRONENBORN, AM ;
CLORE, GM .
JOURNAL OF MAGNETIC RESONANCE, 1991, 95 (01) :214-220